Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Resveratrol wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
9 of 11 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
9 of 11 studies with measurable effects showed benefit.
Top outcomes
150-500mg trans-resveratrol
With a meal containing fat
Trans-resveratrol capsules
40-80mg isoflavones daily
Divided doses with meals, Consistent daily timing
Standardized soy isoflavone extract
4-12 weeks
4-8 weeks
4-12 weeks
6-12 months
8-12 weeks
Initial use
A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Impact of Resveratrol Supplementation on Anthropometric Indices in Patients With Type 2 Diabetes
Phytotherapy research : PTR (2025) · Meta analysis · n=614
We determined overall effect sizes using a random-effects model and assessed heterogeneity using the I 2 statistic and Cochrane's Q test.
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
International journal of molecular sciences (2024) · Systematic review · n=200
Over the last 20 years, there have been almost 200 studies evaluating resveratrol across at least 24 indications, including cancer, menopause symptoms, diabetes, metabolic syndrome, and cardiovascular disease.
Resveratrol and Female Fertility: A Systematic Review
International journal of molecular sciences (2024) · Systematic review
The current literature, though limited, suggests that resveratrol may play a role in female infertility.
Soy isoflavones prevent bone resorption and loss, a systematic review and meta-analysis of randomized controlled trials
Critical reviews in food science and nutrition (2020) · Meta analysis · n=5313
Soy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.
Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Advances in nutrition (Bethesda, Md.) (2025) · Meta analysis · n=3285
Addressing public health concerns may promote soy foods as high-quality plant protein sources with low environmental impact and cost, particularly benefiting postmenopausal women and aligning with sustainable dietary patterns and guidelines.
Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis
PeerJ (2025) · Meta analysis · n=533
In October 2024, we screened 2,099 articles, of which 12 were eligible for meta-analysis, and found that soy isoflavones were effective for treating menopausal symptoms (seven studies, 533 participants, Hedges' g = -0.25, 95% CI [-0.42 to -0.08], p = 0.00).
Based on meta-analysis showing TNF-α reduction in young and obese subjects. Effect sizes were modest and heterogeneity was high (I2=60-74%). Higher doses associated with increased GI upset risk.
Meta-analysis of 533 participants showed effectiveness for menopausal symptoms. Effect size appears modest and heterogeneity was noted across studies. Individual response varies significantly.
AI-estimated from published studies. Interpret as directional guidance.
Resveratrol has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For menopause support, Soy Isoflavones has a higher relevance score (90 vs 75).
No known interactions between Resveratrol and Soy Isoflavones have been documented in our database. However, always consult a healthcare provider before combining supplements.